UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Awareness in Atypical Thrombotic Microangiopathies

The oncologist (Dayton, Ohio), 2009-08, Vol.14 (8), p.769-779

2009

Volltextzugriff (PDF)

Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy

Gastroenterology (New York, N.Y. 1943), 2014-02, Vol.146 (2), p.401-411.e1

2014

Volltextzugriff (PDF)

Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients

Journal of oncology pharmacy practice, 2023-07, Vol.29 (5), p.1154-1162

2023

Volltextzugriff (PDF)

Impact of granulocyte colony‐stimulating factor on FOLFIRINOX‐induced neutropenia prevention: A population pharmacokinetic/pharmacodynamic approach

British journal of clinical pharmacology, 2020-12, Vol.86 (12), p.2473-2485

2020

Volltextzugriff (PDF)

Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial

European journal of cancer (1990), 2023-12, Vol.195, p.113400-113400, Article 113400

2023

Volltextzugriff (PDF)

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer

Health and quality of life outcomes, 2021-02, Vol.19 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

Long-term response to Olaparib in carcinomatous meningitis of a BRCA2 mutated ovarian cancer: A case report

Molecular and clinical oncology, 2020-07, Vol.13 (1), p.73-75

2020

Volltextzugriff (PDF)

Ovarian cancer in the older patient: where are we now? What to do next?

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231192397-17588359231192397

2023

Volltextzugriff (PDF)

Improving olaparib exposure to optimize adverse effects management

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359241248328-17588359241248328

2024

Volltextzugriff (PDF)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation

Cancer reports, 2023-05, Vol.6 (5), p.e1823-n/a

2023

Volltextzugriff (PDF)

FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts

World journal of gastroenterology : WJG, 2012-09, Vol.18 (33), p.4533-4541

Neuzillet, Cindy

2012

Volltextzugriff (PDF)

Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions

Drugs & aging, 2023-09, Vol.40 (9), p.837-846

2023

Volltextzugriff (PDF)

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3107-3115

2014

Volltextzugriff (PDF)

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

Nature communications, 2024-07, Vol.15 (1), p.5931-11, Article 5931

2024

Volltextzugriff (PDF)

Taking care of older patients with cancer in the context of COVID-19 pandemic

The lancet oncology, 2020-05, Vol.21 (5), p.e236-e236

2020

Volltextzugriff (PDF)

PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports

Molecular medicine reports, 2021-01, Vol.23 (1), Article 75

2021

Volltextzugriff (PDF)

Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial

Journal of the National Comprehensive Cancer Network, 2023-12, Vol.21 (12), p.1234-1242.e17

2023

Volltextzugriff (PDF)

Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy

World journal of gastroenterology : WJG, 2016-11, Vol.22 (42), p.9378-9386

2016

Volltextzugriff (PDF)

Le cycle cellulaire et ses cibles: inhibition des CDK

Bulletin du cancer, 2012-02, Vol.99 (2), p.163-171

2012

Volltextzugriff (PDF)

Simplified Prognostic Model in Patients with Oxaliplatin‐Based or Irinotecan‐Based First‐Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

The oncologist (Dayton, Ohio), 2011-09, Vol.16 (9), p.1228-1238

2011

Volltextzugriff (PDF)

Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)

Digestive and liver disease, 2020-05, Vol.52 (5), p.493-505

2020

Volltextzugriff (PDF)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure

Pharmaceuticals (Basel, Switzerland), 2020-11, Vol.13 (11), p.416

2020

Volltextzugriff (PDF)

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice

Cancers, 2022-03, Vol.14 (7), p.1675

2022

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(62)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(35)
Oncology
(31)
Female
(23)
Aged
(20)
Chemotherapy
(20)
Life Sciences
(18)
Cancer
(17)
Male
(14)
Middle Aged
(13)
Aged, 80 And Over
(12)
Cancer Therapies
(11)
Ovarian Cancer
(11)
Patients
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Treatment Outcome
(10)
Adult
(9)
Fluorouracil - Administration & Dosage
(9)
Colorectal Neoplasms - Pathology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis

Cancer Awareness in Atypical Thrombotic Microangiopathies

Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy

Adherence to oral anti-cancer therapies in older patients is similar to that of younger patients

Impact of granulocyte colony‐stimulating factor on FOLFIRINOX‐induced neutropenia prevention: A population pharmacokinetic/pharmacodynamic approach

Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer

Long-term response to Olaparib in carcinomatous meningitis of a BRCA2 mutated ovarian cancer: A case report

Ovarian cancer in the older patient: where are we now? What to do next?

Improving olaparib exposure to optimize adverse effects management

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation

FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts

Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of Coprescriptions

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

Taking care of older patients with cancer in the context of COVID-19 pandemic

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial

PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports

Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial

Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy

Le cycle cellulaire et ses cibles: inhibition des CDK

Simplified Prognostic Model in Patients with Oxaliplatin‐Based or Irinotecan‐Based First‐Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study

Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice

Suchergebnisse filtern